For: | Brunetto MR, Colombatto P, Bonino F. Bio-mathematical models of viral dynamics to tailor antiviral therapy in chronic viral hepatitis. World J Gastroenterol 2009; 15(5): 531-537 [PMID: 19195054 DOI: 10.3748/wjg.15.531] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v15/i5/531.htm |
Number | Citing Articles |
1 |
Q. Zheng, Y. Y. Zhu, J. Chen, Y. R. Liu, J. You, J. Dong, D. W. Zeng, L. Y. Gao, L. H. Chen, J. J. Jiang. Decline in intrahepatic cccDNA and increase in immune cell reactivity after 12 weeks of antiviral treatment were associated with HBeAg loss. Journal of Viral Hepatitis 2014; 21(12): 909 doi: 10.1111/jvh.12261
|
2 |
Barbara Locke, Eva Forsgren, Ingemar Fries, Joachim R. de Miranda. Acaricide Treatment Affects Viral Dynamics in Varroa destructor-Infested Honey Bee Colonies via both Host Physiology and Mite Control. Applied and Environmental Microbiology 2012; 78(1): 227 doi: 10.1128/AEM.06094-11
|
3 |
Dong Jin Suh, Soon Ho Um, Eva Herrmann, Ju-Hyun Kim, Young Sok Lee, Heon Ju Lee, Myung Seok Lee, Youn-Jae Lee, Weibin Bao, Patricia Lopez, Han Chu Lee, Claudio Avila, Stefan Zeuzem. Early Viral Kinetics of Telbivudine and Entecavir: Results of a 12-Week Randomized Exploratory Study with Patients with HBeAg-Positive Chronic Hepatitis B. Antimicrobial Agents and Chemotherapy 2010; 54(3): 1242 doi: 10.1128/AAC.01163-09
|
4 |
|
5 |
Jörg Petersen, Maria Buti. Considerations for the long-term treatment of chronic hepatitis B with nucleos(t)ide analogs. Expert Review of Gastroenterology & Hepatology 2012; 6(6): 683 doi: 10.1586/egh.12.52
|
6 |
Joachim R de Miranda, Lesley Bailey, Brenda V Ball, Philippe Blanchard, Giles E Budge, Nor Chejanovsky, Yan-Ping Chen, Laurent Gauthier, Elke Genersch, Dirk C de Graaf, Magali Ribière, Eugene Ryabov, Lina De Smet, Jozef J M van der Steen. Standard methods for virus research inApis mellifera. Journal of Apicultural Research 2013; 52(4): 1 doi: 10.3896/IBRA.1.52.4.22
|
7 |
Christian W W Pirk, Joachim R de Miranda, Matthew Kramer, Tomàs E Murray, Francesco Nazzi, Dave Shutler, Jozef J M van der Steen, Coby van Dooremalen. Statistical guidelines forApis melliferaresearch. Journal of Apicultural Research 2013; 52(4): 1 doi: 10.3896/IBRA.1.52.4.13
|
8 |
Thomas A. O’Shea-Wheller, Frank D. Rinkevich, Robert G. Danka, Michael Simone-Finstrom, Philip G. Tokarz, Kristen B. Healy. A derived honey bee stock confers resistance to Varroa destructor and associated viral transmission. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-08643-w
|
9 |
E Ahmed, HA El-Saka. On multi-strain model for Hepatitis C. Nonlinear Biomedical Physics 2011; 5(1) doi: 10.1186/1753-4631-5-6
|
10 |
Marco Montagnani, Marina Giandinoto, Andrea Lisotti, Silvia Galli, Francesco Azzaroli, Federica Buonfiglioli, Laura Turco, Rita Aldini, Giuseppe Mazzella. High Dose Lamivudine in HBV-Related Cirrhotic Patients with Unsatisfactory Response After Adefovir Add-On. Digestive Diseases and Sciences 2012; 57(2): 561 doi: 10.1007/s10620-011-1873-x
|
11 |
Clara Balsano, Patrizia Burra, Christophe Duvoux, Anna Alisi, Fabio Piscaglia, Alessio Gerussi, Maurizia Rossana Brunetto, Ferruccio Bonino, Roberto Montalti, Silvia Campanile, Marcello Persico, Domenico Alvaro, Silvano Santini, Pietro Invernizzi, Marco Carbone, Mario Masarone, Albino Eccher, Bruno Siciliano, Mario Vento, Fanny Ficuciello, Federico Cabitza, Simone Penasa, Piergiorgio Donatelli. Artificial Intelligence and liver: Opportunities and barriers. Digestive and Liver Disease 2023; 55(11): 1455 doi: 10.1016/j.dld.2023.08.048
|
12 |
Harel Dahari, Jeremie Guedj, Alan S. Perelson, Thomas J. Layden. Hepatitis C Viral Kinetics in the Era of Direct Acting Antiviral Agents and Interleukin-28B. Current Hepatitis Reports 2011; 10(3): 214 doi: 10.1007/s11901-011-0101-7
|
13 |
Nancy W. Y. Leung, Eva Herrmann, George K. K. Lau, Henry L. Y. Chan, Tokutei M. K. So, Stefan Zeuzem, Yu Dong, Aldo Trylesinski, Nikolai V. Naoumov. Early Viral Kinetics with Telbivudine, Tenofovir or Combination of Both in Immunotolerant Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B. Infectious Diseases and Therapy 2014; 3(2): 191 doi: 10.1007/s40121-014-0039-5
|
14 |
Bruno C. de Sousa, Celso Cunha, Andrew Yates. Development of Mathematical Models for the Analysis of Hepatitis Delta Virus Viral Dynamics. PLoS ONE 2010; 5(9): e12512 doi: 10.1371/journal.pone.0012512
|
15 |
T. Bader. Does fluvastatin favour HCV replicationin vivo? A pilot study on HIV-HCV co-infected patients. Journal of Viral Hepatitis 2010; 17(3): 227 doi: 10.1111/j.1365-2893.2009.01185.x
|
16 |
P. Colombatto, M. R. Brunetto, A. M. Maina, V. Romagnoli, P. Almasio, M. G. Rumi, A. Ascione, G. Pinzello, M. Mondelli, L. Muratori, R. Rappuoli, D. Rosa, M. Houghton, S. Abrignani, F. Bonino. HCV E1E2‐MF59 vaccine in chronic hepatitis C patients treated with PEG‐IFNα2a and Ribavirin: a randomized controlled trial. Journal of Viral Hepatitis 2014; 21(7): 458 doi: 10.1111/jvh.12163
|
17 |
E Ahmed, H A El-Saka. On fractional order models for Hepatitis C. Nonlinear Biomedical Physics 2010; 4(1) doi: 10.1186/1753-4631-4-1
|